Dark

BGMD
BG MEDICINE INC
stock OTC

Inactive

Oct 18, 2021

0.000100USD-99.000%(-0.009900)303

Pre-market

0.00USD-100.000%(-0.01)0

After-hours

0.00USD0.000%(0.00)0

OverviewHistoricalExchangesShortsTrends

open chart

CEO

Paul Sohmer

Headquarters

Foxboro, Massachusetts, USA

Industry

Drugs

Last Split

Jul 9, 20151for4reverse

Profile

bg medicine, inc. (nasdaq:bgmd), the developer of the bgm galectin-3® test, is focused on the development and delivery of diagnostic solutions to aid in the clinical management of heart failure and related disorders. for additional information about bg medicine, heart failure and galectin-3 testing, please visit www.bg-medicine.com.

.dark-mode .Kcn6VJ{ color: white; background-color: #333333; border: 2px solid white; }.light-mode .Kcn6VJ{ color: #333333; background-color: white; border: 2px solid #333333; }BGMDBG MEDICINE INCstock OTC

BGMD
BG MEDICINE INC
stock OTC